Halozyme
HALO
210 hedge funds and large institutions have $1.96B invested in Halozyme in 2019 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 63 increasing their positions, 72 reducing their positions, and 22 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
174% more call options, than puts
Call options by funds: $13.8M | Put options by funds: $5.03M
36% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 22
4% more funds holding
Funds holding: 202 → 210 (+8)
2.19% more ownership
Funds ownership: 84.26% → 86.45% (+2.2%)
7% less capital invested
Capital invested by funds: $2.1B → $1.96B (-$143M)
13% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 72
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$30.9M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$25.4M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$21.3M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$19.1M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$17.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$20.4M |
| 2 |
TS
Third Security
Radford,
Virginia
|
-$16.6M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$11.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$10.8M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$8.81M |
HALO Hedge Fund Activity: Q3 2019 in Review
210 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2019, worth a combined $1.96B — down 6.8% from $2.1B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new HALO positions and 22 closed out — a net gain of 8 holders — while 63 added to existing stakes and 72 trimmed.
The largest buyer was William Blair Investment Management, adding an estimated $30.9M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $20.4M sold.
- 210 institutional investors held Halozyme (HALO) as of Q3 2019, up from 202 in Q2 2019.
- Funds reported $1.96B of Halozyme stock for Q3 2019, down 6.8% quarter-over-quarter.
- 30 funds opened new Halozyme positions in Q3 2019 and 22 closed out, a net change of +8 holders.
- The largest Halozyme buyer in Q3 2019 was William Blair Investment Management, an estimated $30.9M added.
- The largest Halozyme seller in Q3 2019 was Point72 Asset Management, an estimated $20.4M sold.
Based on aggregated 13F filings for Q3 2019.